[
  {
    "title": "Insulet Gains 62.9% in a Year: What's Driving the Stock?",
    "published": 1742818140,
    "posting_price": 272.38000488,
    "close_price": 273.17999268,
    "percent_change": 0.29370284
  },
  {
    "title": "Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%",
    "published": 1742663687
  },
  {
    "title": "PODD Stock Gains Following the Launch of Omnipod 5 in Australia",
    "published": 1742574960,
    "posting_price": 263.47000122,
    "close_price": 268.32000732,
    "percent_change": 1.8408191
  },
  {
    "title": "Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers",
    "published": 1742547961,
    "posting_price": 263.47000122,
    "close_price": 268.32000732,
    "percent_change": 1.8408191
  },
  {
    "title": "PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5",
    "published": 1742488860,
    "posting_price": 264.5,
    "close_price": 265.39001465,
    "percent_change": 0.33648947
  },
  {
    "title": "LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day",
    "published": 1742473380,
    "posting_price": 264.5,
    "close_price": 265.39001465,
    "percent_change": 0.33648947
  },
  {
    "title": "Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data",
    "published": 1742464483,
    "posting_price": 264.5,
    "close_price": 265.39001465,
    "percent_change": 0.33648947
  },
  {
    "title": "Insulet\u2019s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod\u00ae 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections",
    "published": 1742414460,
    "posting_price": 261.42999268,
    "close_price": 265.82000732,
    "percent_change": 1.67923144
  },
  {
    "title": "3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan",
    "published": 1742396580,
    "posting_price": 261.42999268,
    "close_price": 265.82000732,
    "percent_change": 1.67923144
  },
  {
    "title": "Insulet Announces Pricing of Senior Notes Due 2033",
    "published": 1742329920,
    "posting_price": 261.25,
    "close_price": 260.47000122,
    "percent_change": -0.29856413
  },
  {
    "title": "Insulet Chief Technology Officer Mark Field leaves",
    "published": 1742308547,
    "posting_price": 261.25,
    "close_price": 260.47000122,
    "percent_change": -0.29856413
  },
  {
    "title": "Insulet Expands Omnipod\u00ae 5 to Four More International Markets",
    "published": 1742292300,
    "posting_price": 261.25,
    "close_price": 260.47000122,
    "percent_change": -0.29856413
  },
  {
    "title": "From Injections to Innovation \u2013 Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod\u00ae 5 in Adults and Children with Type 1 Diabetes",
    "published": 1742292000,
    "posting_price": 261.25,
    "close_price": 260.47000122,
    "percent_change": -0.29856413
  },
  {
    "title": "Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease",
    "published": 1741715794,
    "posting_price": 238.02000427,
    "close_price": 245.3500061,
    "percent_change": 3.07957386
  },
  {
    "title": "Robinhood initiated, MongoDB downgraded: Wall Street\u2019s top analyst calls",
    "published": 1741358484,
    "posting_price": 259.48001099,
    "close_price": 251.80999756,
    "percent_change": -2.95591687
  },
  {
    "title": "Tandem\u2019s insulin pump tech wins FDA nod for Type 2 diabetes",
    "published": 1740656959,
    "posting_price": 269.51000977,
    "close_price": 267.08999634,
    "percent_change": -0.89793082
  },
  {
    "title": "Reflecting On Patient Monitoring Stocks\u2019 Q4 Earnings: DexCom (NASDAQ:DXCM)",
    "published": 1740647109,
    "posting_price": 269.51000977,
    "close_price": 267.08999634,
    "percent_change": -0.89793082
  },
  {
    "title": "Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick",
    "published": 1713189006,
    "posting_price": 176.41999817,
    "close_price": 173.94000244,
    "percent_change": -1.40573391
  },
  {
    "title": "7 Stable Stocks for 50% Returns by Early 2025",
    "published": 1713188730,
    "posting_price": 176.41999817,
    "close_price": 173.94000244,
    "percent_change": -1.40573391
  },
  {
    "title": "Earnings growth outpaced the impressive 16% CAGR delivered to Insulet (NASDAQ:PODD) shareholders over the last five years",
    "published": 1713180550,
    "posting_price": 176.41999817,
    "close_price": 173.94000244,
    "percent_change": -1.40573391
  },
  {
    "title": "Wall Street Breakfast: What Moved Markets",
    "published": 1712990543
  },
  {
    "title": "Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?",
    "published": 1712938215,
    "posting_price": 177.63000488,
    "close_price": 175.22000122,
    "percent_change": -1.35675482
  },
  {
    "title": "ClearBridge Aggressive Growth Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712906400,
    "posting_price": 177.63000488,
    "close_price": 175.22000122,
    "percent_change": -1.35675482
  },
  {
    "title": "Insulet (PODD) Stock Moves -0.34%: What You Should Know",
    "published": 1712787320,
    "posting_price": 174.08000183,
    "close_price": 177.41000366,
    "percent_change": 1.91291463
  },
  {
    "title": "Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands",
    "published": 1712750760,
    "posting_price": 174.08000183,
    "close_price": 177.41000366,
    "percent_change": 1.91291463
  },
  {
    "title": "New additions to Goldman\u2019s High Operating Leverage list",
    "published": 1712746860,
    "posting_price": 174.08000183,
    "close_price": 177.41000366,
    "percent_change": 1.91291463
  },
  {
    "title": "Citi\u2019s value focus list of small and mid-caps",
    "published": 1712563980,
    "posting_price": 166.30000305,
    "close_price": 170.03999329,
    "percent_change": 2.24894177
  },
  {
    "title": "SPY ETF Update, 4/8/2024",
    "published": 1712554200,
    "posting_price": 166.30000305,
    "close_price": 170.03999329,
    "percent_change": 2.24894177
  },
  {
    "title": "Top buy-rated stocks and sell-rated stocks within Health Care - Citi",
    "published": 1712225880,
    "posting_price": 165.72999573,
    "close_price": 163.25,
    "percent_change": -1.49640729
  },
  {
    "title": "SPY ETF Update, 4/4/2024\ufffd\ufffd\ufffd",
    "published": 1712194620,
    "posting_price": 165.72999573,
    "close_price": 163.25,
    "percent_change": -1.49640729
  },
  {
    "title": "Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024",
    "published": 1712138400,
    "posting_price": 163.25,
    "close_price": 164.86000061,
    "percent_change": 0.98621783
  },
  {
    "title": "Here's Why Insulet (PODD) is a Strong Growth Stock",
    "published": 1712065504,
    "posting_price": 166.50999451,
    "close_price": 164.05000305,
    "percent_change": -1.47738367
  },
  {
    "title": "5 Medical Product Stocks to Buy Amid Industry Challenges",
    "published": 1712061300,
    "posting_price": 166.50999451,
    "close_price": 164.05000305,
    "percent_change": -1.47738367
  },
  {
    "title": "SPY ETF Update, 4/2/2024",
    "published": 1712039160,
    "posting_price": 166.50999451,
    "close_price": 164.05000305,
    "percent_change": -1.47738367
  },
  {
    "title": "Buy vs. Sell ideas paired within each sector - Oppenheimer",
    "published": 1712025420,
    "posting_price": 166.50999451,
    "close_price": 164.05000305,
    "percent_change": -1.47738367
  }
]